These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 1102553)
21. Does a positive oestrogen feedback on the hypothalamic-pituitary axis exist concurrently with a defective testosterone feedback in Klinefelter's syndrome? Goh VH; Lee KO Horm Res; 1998 Sep; 50(3):160-5. PubMed ID: 9762005 [TBL] [Abstract][Full Text] [Related]
22. Estrogen inhibits luteinizing hormone (LH), but not follicle-stimulating hormone secretion in hypophysectomized pituitary-grafted rats receiving pulsatile LH-releasing hormone infusions. Strobl FJ; Levine JE Endocrinology; 1988 Jul; 123(1):622-30. PubMed ID: 3133202 [TBL] [Abstract][Full Text] [Related]
24. Modulation of the gonadotropin response to constant luteinizing hormone-releasing hormone infusion by acute and chronic testosterone administration in Klinefelter's syndrome. Smals AG; Kloppenborg PW; Pieters GF; Hoefnagels WH; Lequin RM; Benraad TJ J Clin Endocrinol Metab; 1979 Jan; 48(1):148-52. PubMed ID: 370138 [No Abstract] [Full Text] [Related]
25. [Investigation of the gonadotrophins and prolactin in sterile men (the LH-RH + TRH test) (author's transl)]. Boucher D; Hermabessiere J; Grizard G; Doly M; Bruhat M Rev Fr Gynecol Obstet; 1977 Oct; 72(10):631-40, 641-4. PubMed ID: 413178 [TBL] [Abstract][Full Text] [Related]
26. Studies using releasing factors in Klinefelter's syndrome: the responses of LH and FSH to luteinizing hormone-releasing hormone and of prolactin and TSH to thyrotropin-releasing hormone before and after testosterone. Cheikh IE; Hamilton BP; Hsu TH; Wiswell JG Psychoneuroendocrinology; 1981; 6(1):37-44. PubMed ID: 6787634 [No Abstract] [Full Text] [Related]
27. Pituitary-testicular responses of estradiol-17 beta-implanted bull calves to continuous versus pulsatile infusion of luteinizing hormone releasing hormone. Schanbacher BD J Anim Sci; 1984 Apr; 58(4):943-8. PubMed ID: 6427169 [TBL] [Abstract][Full Text] [Related]
28. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men. Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019 [TBL] [Abstract][Full Text] [Related]
29. Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men. Pavlou SN; Interlandi JW; Wakefield G; Island DP; Rivier J; Vale W; Kovacs WJ J Clin Endocrinol Metab; 1987 May; 64(5):1070-4. PubMed ID: 3104387 [TBL] [Abstract][Full Text] [Related]
30. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578 [TBL] [Abstract][Full Text] [Related]
31. The effect of short-term testosterone administration on serum FSH, LH and testosterone levels: evidence for selective abnormality in LH control in patients with Klinefelter's syndrome. Capell PT; Paulsen CA; Derleth D; Skoglund R; Plymate S J Clin Endocrinol Metab; 1973 Nov; 37(5):752-9. PubMed ID: 4749449 [No Abstract] [Full Text] [Related]
32. Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men. Snyder PJ; Reitano JF; Utiger RD J Clin Endocrinol Metab; 1975 Nov; 41(5):938-45. PubMed ID: 1102556 [TBL] [Abstract][Full Text] [Related]
33. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977 [TBL] [Abstract][Full Text] [Related]
34. Alterations during the estrous cycle in the responsiveness of the pituitary to subcutaneous administration of synthetic LH-releasing hormone (LHRH). Zeballos G; McCann SM Endocrinology; 1975 Jun; 96(6):1377-85. PubMed ID: 1092542 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505 [TBL] [Abstract][Full Text] [Related]
36. 47,XXY Klinefelter's syndrome with low FSH and LH levels and absence of Leydig cells. Nistal M; Paniagua R; Abaurrea MA; Pallardo LF Andrologia; 1980; 12(5):426-33. PubMed ID: 6778256 [TBL] [Abstract][Full Text] [Related]
37. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man. Gross KM; Matsumoto AM; Bremner WJ J Clin Endocrinol Metab; 1987 Apr; 64(4):675-80. PubMed ID: 3102545 [TBL] [Abstract][Full Text] [Related]
38. Selective effect of androgens on LH and FSH release in anterior pituitary cells in culture. Drouin J; Labrie F Endocrinology; 1976 Jun; 98(6):1528-34. PubMed ID: 132345 [TBL] [Abstract][Full Text] [Related]
39. Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men. Schnorr JA; Bray MJ; Veldhuis JD J Clin Endocrinol Metab; 2001 Jun; 86(6):2600-6. PubMed ID: 11397860 [TBL] [Abstract][Full Text] [Related]
40. Effects of LHRH and long-acting LHRH on serum LH and FSH levels of healthy women. Bartfai G; Sas M; Morvay J; Julesz J; Laszlo FA J Endocrinol Invest; 1981; 4(3):359-62. PubMed ID: 6798097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]